Heidi Hagen Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Heidi Hagen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Heidi Hagen. Heidi Hagen is a in Vericel Corp ($ASTM) and a Director in Vericel Corp ($ASTM) and a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a Interim CEO in ZIOPHARM ONCOLOGY INC ($ZIOP).
Address: C/O AASTROM BIOSCIENCES, INC. P.O. BOX 376 ANN ARBOR 48106 MI
Companies in which Heidi Hagen is an Insider
Vericel Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Heidi Hagen:
Holdings: 5,000 shares
Latest Transaction: May 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Heidi Hagen: Interim CEO, Director
Holdings: 122,119 shares
Current Value: $818,197
Latest Transaction: Mar 08 2021
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Heidi Hagen
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | M | 4.12 | 3,000 | 12,360 | 0 | ||
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | M | 6.00 | 2,250 | 13,500 | 0 | ||
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Option Exercise | M | 6.00 | 1,500 | 9,000 | 0 | ||
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Buy | M | 6.00 | 2,250 | 13,500 | 10,250 | 8 K to 10.3 K (+28.13 %) | |
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Buy | M | 4.12 | 3,000 | 12,360 | 8,000 | 5 K to 8 K (+60.00 %) | |
| May 20 2021 | ASTM | Vericel Corp | Hagen Heidi | Buy | M | 6.00 | 1,500 | 9,000 | 5,000 | 3.5 K to 5 K (+42.86 %) | |
| Mar 08 2021 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Interim CEO | Option Exercise | A | 4.31 | 675,000 | 2,909,250 | 675,000 |